Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Conditions

• Advanced Esophageal Squamous Cell Carcinoma
• Advanced Renal Cell Carcinoma
• Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IIB Cutaneous Melanoma AJCC v8
• Clinical Stage IIC Cutaneous Melanoma AJCC v8
• Clinical Stage III Cutaneous Melanoma AJCC v8
• Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
• Clinical Stage IV Cutaneous Melanoma AJCC v8
• Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
• Esophageal Carcinoma
• Gastroesophageal Junction Adenocarcinoma
• Hepatocellular Carcinoma
• Locally Advanced Urothelial Carcinoma
• Lung Non-Small Cell Carcinoma
• Malignant Solid Neoplasm
• Metastatic Colorectal Carcinoma
• Metastatic Cutaneous Melanoma
• Metastatic Esophageal Squamous Cell Carcinoma
• Metastatic Head and Neck Squamous Cell Carcinoma
• Metastatic Urothelial Carcinoma
• Recurrent Esophageal Squamous Cell Carcinoma
• Recurrent Head and Neck Squamous Cell Carcinoma
• Renal Cell Carcinoma
• Stage III Renal Cell Cancer AJCC v8
• Stage IV Colorectal Cancer AJCC v8
• Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
• Stage IV Renal Cell Cancer AJCC v8
• Unresectable Cutaneous Melanoma
• Unresectable Esophageal Squamous Cell Carcinoma
• Urothelial Carcinoma
• Unresectable Urothelial Carcinoma

Interventions

• OTHER: Home Health Encounter
• BIOLOGICAL: Nivolumab
• PROCEDURE: Patient Monitoring
• OTHER: Questionnaire Administration

Sponsor

Mayo Clinic